Gene: STYXL1
Official Full Name: serine/threonine/tyrosine interacting like 1provided by HGNC
Gene Summary: Enables protein phosphatase binding activity and pseudophosphatase activity. Involved in negative regulation of stress granule assembly; positive regulation of intrinsic apoptotic signaling pathway; and positive regulation of neuron projection development. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00230 | STYXL1 Knockout cell line (HeLa) | Human | STYXL1 | 1:3~1:6 | Negative | Online Inquiry |
KO00231 | STYXL1 Knockout cell line (HEK293) | Human | STYXL1 | 1:3~1:6 | Negative | Online Inquiry |
KO22313 | STYXL1 Knockout cell line (HCT 116) | Human | STYXL1 | 1:2~1:4 | Negative | Online Inquiry |
KO22314 | STYXL1 Knockout cell line (A549) | Human | STYXL1 | 1:3~1:4 | Negative | Online Inquiry |
STYXL1 Gene Knockout Cell Lines are genetically engineered cell models designed to specifically disrupt the STYXL1 gene, which encodes a protein involved in various cellular signaling pathways and biochemical processes. By employing CRISPR/Cas9 technology, these cell lines facilitate precise gene editing, allowing researchers to create knockout models that elucidate the role of STYXL1 in cellular functions, disease mechanisms, and therapeutic responses.
Key functions of STYXL1 include its involvement in regulating protein phosphorylation and mediating stress responses, influencing processes such as apoptosis, cell growth, and differentiation. By utilizing the STYXL1 knockout cell lines, scientists can investigate the downstream effects of STYXL1 loss on various signaling pathways, thereby revealing the potential implications in diseases such as cancer and neurodegeneration. The knockout models serve as invaluable tools in research settings, enabling in-depth studies of gene function, drug discovery, and the development of novel therapeutic strategies.
One of the significant advantages of STYXL1 Gene Knockout Cell Lines is their robustness and reproducibility, which are critical for obtaining reliable experimental results. Compared to traditional methods of gene knockdown, such as siRNA or shRNA approaches, knockout models provide a complete and stable loss-of-function scenario, ensuring greater insights into gene roles. Additionally, these cell lines are readily adaptable to high-throughput screening environments, accelerating the pace of research and discovery.
The scientific community benefits greatly from STYXL1 Gene Knockout Cell Lines, as they equip researchers and clinicians with the capability to dissect complex biological responses in relevant model systems. By facilitating the exploration of STYXL1's role in health and disease, these knockout lines hold promise for identifying novel biomarkers and therapeutic targets, driving innovation in personalized medicine.
As a leading provider of advanced genetic tools, our company is committed to empowering researchers with high-quality biological products. Our deep expertise in gene editing and cell line development ensures that our STYXL1 Gene Knockout Cell Lines meet the highest standards of performance and reliability, contributing to groundbreaking discoveries in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.